Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemo bioscience has over 20 years of experience developing and manufacturing high-quality immunohematology reagents for blood typing and transfusion diagnostics. Their product line includes a comprehensive suite of solutions for blood banks and clinical laboratories such as Blood Typing Reagents (targeting various red cell antigens), Quality Controls for manual/automated systems, Potentiators to enhance hemagglutination assays, Elution Kits for antibody identification, specialist solutions for red cell treatment/preservation, educational materials (MedTEK), proficiency testing materials customized to client needs, validation kits for method validation/competency testing[1][2][4]. The company operates an FDA registered manufacturing facility with cGMP standards[3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemo bioscience.